Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCA versus oral oxycodone titration for cancer pain
ChiCTR2000037845Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydromorphone and oxycodone in cancer pain (2 arms), sponsored by Tongji Hospital. Primary endpoint: Time to successful titration. Started Sep 2020; status: recruiting.
02
Drugs
hydromorphoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2000037845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037845.